The major variant of concerns (VOCs) have shared mutations in severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spike proteins, mostly on the S1 unit and resulted in …

Abstract Introduction An epidemic of Coronavirus Disease 2019 (COVID-19) began in
December 2019 in China leading to a Public Health Emergency of International Concern …

Background The clinical presentation of European patients with mild‐to‐moderate COVID‐
19 infection is still unknown. Objective To study the clinical presentation of COVID‐19 in …

In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2
infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond …

SARS-CoV-2 is a SARS-like coronavirus of likely zoonotic origin first identified in December
2019 in Wuhan, the capital of China's Hubei province. The virus has since spread globally …

Objective To evaluate a reverse transcription loop-mediated isothermal amplification (RT-
LAMP) assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

The recently emerged novel coronavirus,“severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2)”, caused a highly contagious disease called coronavirus disease 2019 …

The coronavirus (COVID-19) pandemic is putting healthcare systems across the world under
unprecedented and increasing pressure according to the World Health Organization (WHO) …

Computer-aided diagnosis (CAD) methods such as Chest X-rays (CXR)-based method is
one of the cheapest alternative options to diagnose the early stage of COVID-19 disease …

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible
for the coronavirus disease COVID-19, a public health emergency worldwide, and Italy is …